IgniteData's Archer Revolutionizes Clinical Research Data Transfer
Revolutionizing Clinical Trials with Archer
IgniteData is at the forefront of transforming clinical research data management with the expansion of its flagship platform, Archer. This innovative solution is now utilized by many of the world's esteemed research institutions, setting a new standard for clinical trial data automation. Archer facilitates a seamless regulatory-grade transfer of Electronic Health Record (EHR) data to Electronic Data Capture (EDC) systems as well as from eSource directly to sponsors, showcasing IgniteData's commitment to advance the healthcare landscape.
Significant Growth and Global Presence
In a remarkable turnaround, the Archer platform has seen extensive adoption by leading Academic Medical Centers globally within just a year. Specializing in various medical fields such as Cardiovascular, Endocrinology, and Oncology, Archer's acceptance is notable. A staggering 70% of National Cancer Institute-designated cancer centers have embraced or are in the process of integrating Archer, which includes 8 out of the top 10 as ranked by US News and World Report, reinforcing its reliability in clinical data transfer.
IgniteData's expansion is evidenced by a significant increase in the Archer Network, growing by 250% in a recent year and an extraordinary increase of 287% in the current year. The company plans to broaden its outreach, estimating to connect with over 50 leading research facilities, which would symbolize a network exceeding 1,000 sites globally. This exponential growth positions IgniteData as one of the fastest-evolving players in the Healthcare IT sector.
Driving Efficiency with Archer
Dr. Jose Galvez, Chief Medical Information Officer of IgniteData, highlights key contributors to Archer's adoption. He notes that the deployment process has been streamlined from weeks to mere days, making it easier for new investigator-initiated trials and studies from sponsors to be integrated swiftly. This remarkable flexibility and scalability allow the platform to accommodate the diverse needs of research institutions efficiently.
Seamless Interoperability and Compliance
The Archer platform serves as the essential connection between research sites and sponsors. It facilitates real-time transfer of source data from EHR systems, such as Epic and Cerner, into sponsor databases like Medidata and Veeva. This capability significantly diminishes the need for manual data entry while ensuring comprehensive audit trails. Designed for interoperability, Archer can adapt to various healthcare systems, optimizing efficacy and minimizing coordinator workloads.
“The goal is not to transfer excessive amounts of data but to deliver the right data punctually, maintaining full auditability and data integrity,” said Dr. Galvez, emphasizing the platform's focus on quality over quantity.
A Comprehensive Solution for Today's Clinical Research Needs
Archer is built with a strong emphasis on maintaining data privacy and ensuring compliance with current regulatory standards. Not only does it conform to all necessary regulations, but it is positioned to exceed them, setting a benchmark for future-ready capabilities within an evolving healthcare and life sciences environment. This approach not only fosters data safety but also builds trust among sponsors and research sites, all while promoting better therapy outcomes for patients.
Leadership Insights into the Future
CEO Zach Taft expresses great confidence in Archer's potential as it enters more prominent research institutions. He notes that Archer is more than just a technological solution; it’s fundamentally changing how data automation in clinical trials is perceived. By going beyond regulatory requirements, Archer instills confidence in data precision, streamlining processes while keeping risks low and budgets manageable.
About IgniteData
IgniteData positions itself as a groundbreaking clinical data technology company striving to streamline the flow of premium electronic health record data into clinical trial frameworks. Archer, its flagship solution, provides a secure, real-time, regulatory-compliant conduit for transferring structured EHR data directly to sponsor EDCs. By reducing the administrative workload on research sites and enhancing data integrity, IgniteData accelerates the timeline of clinical trials. Headquartered in Delaware, the company’s worldwide operations cater to sponsors and research sites on a global scale.
Frequently Asked Questions
What is the Archer platform?
The Archer platform is a clinical research data solution developed by IgniteData that automates the transfer of EHR data to sponsor databases, improving data management in clinical trials.
How has IgniteData expanded its reach?
IgniteData has expanded Archer's deployment to numerous leading research institutions globally, significantly increasing its network and enhancing clinical trial efficiency.
What are the key benefits of using Archer?
Archer offers real-time data transfer, reduces manual entry, ensures compliance with regulatory standards, and enhances data quality, crucial for successful clinical trials.
How does Archer maintain data integrity?
The platform prioritizes data privacy and auditability, ensuring that only necessary data is transferred and that it meets industry regulations.
What is IgniteData's mission?
IgniteData aims to automate high-quality EHR data flow into clinical trial systems, ensuring data compliance, quality, and operational efficiency for research institutions worldwide.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.